# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: GI-IAB: Intraabdominal, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere

Extent: E+W+S+N.I.

Intraabdominal infections must meet at least one of the following criteria:
Patient has organisms cultured from purulent material from intraabdominal space obtained during a surgical operation or needle aspiration
Patient has abscess or other evidence of intraabdominal infection seen during a surgical operation or histopathologic examination
Patient has at leasttwo of the following signs or symptoms with no other recognized cause: fever (> 38 °C), nausea, vomiting, abdominal pain, or jaundice
AND at least one of the following:
organisms cultured from drainage from surgically placed drain (for example, closed suction drainage system, open drain, T-tube drain)
organisms seen on Gram's stain of drainage or tissue obtained during surgical operation or needle aspiration
organisms cultured from blood and radiographic evidence of infection (for example, abnormal findings on ultrasound, CT scan, MRI, or radiolabel scans (gallium, technetium, etc.) or on abdominal X-ray)

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/4/division/4.1/division/4.1.7/division/5 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-4/division-4.1/division-4.1.7/division-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.